Additive Role of ADC Value to ORADS in Adnexal Lesions
NCT07202429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66
Last updated 2025-10-01
Summary
Evaluation of the impact of adding mean apparent diffusion coefficient (ADC mean) measurements to the Ovarian-Adnexal Imaging Reporting and Data System MRI (O-RADS MRI) scoring for adnexal lesion characterization using a combined O-RADS MRI/ADC mean reading approach.
Conditions
- Ovarian Neoplasms
Interventions
- DEVICE
-
MRI
"Multiparametric MRI of adnexal lesions, including conventional sequences, diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) measurement, and dynamic contrast-enhanced (DCE) MRI. Imaging findings were evaluated using the O-RADS MRI scoring system."
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Lamia Salah Eldin, M.D · kasr-alainy cairo university
-
Manar Alaa Eldin Osman, M.D · kasr-alainy cairo university
-
Mohammed Aly Shalaby, M.D · kasr-alainy cairo university
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2024-06-01
- Completion
- 2025-01-01
Countries
- Egypt
Study Locations
More Related Trials
-
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
NCT02156739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Early Prediction of Neoadjuvant Chemotherapy Response in Bladder Cancer Using Quantitative Multiparametric MRI
NCT07202845 ·Status: RECRUITING
-
The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.
NCT02777463 ·Status: COMPLETED
-
18FDG PET Textural Indices in Adrenal Lesion
NCT03469102 ·Status: COMPLETED
-
Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer
NCT02243059 ·Status: WITHDRAWN ·Phase: PHASE4
-
Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.
NCT05340569 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Response to the Neoadjuvant Chemotherapy for Advanced Ovarian Cancer by Multimodal Functional Imaging
NCT02792959 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.
NCT03202199 ·Status: UNKNOWN ·Phase: NA
-
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
NCT02422550 ·Status: RECRUITING
-
Validity of Parametric MRI Using VIRADS
NCT05783271 ·Status: RECRUITING ·Phase: NA
-
A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion
NCT01210027 ·Status: COMPLETED
-
Assessment of Mediastinal Masses With Diffusion Weighted MR Imaging
NCT03214341 ·Status: UNKNOWN
-
Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
NCT00946140 ·Status: COMPLETED
-
Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer
NCT03469726 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574 ·Status: UNKNOWN ·Phase: NA
-
Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging
NCT02798484 ·Status: COMPLETED ·Phase: NA
-
Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer
NCT06232122 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging (MRI) to Predict Outcomes of Pancreatic Ductal Adenocarcinoma (PDAC)
NCT04700488 ·Status: SUSPENDED ·Phase: NA
-
Implications of Biological and Procedural Factors of 18-f FDG Uptake by Normal Organs and Neoplastic Lesions
NCT06626932 ·Status: NOT_YET_RECRUITING
-
Deuterium Metabolic Imaging to Assess Radiotherapy Changes in Glioblastoma Multiforme
NCT05908669 ·Status: ENROLLING_BY_INVITATION
-
PRetreatment MRI for OCcult Liver Metastasis Assessment In Pancreatic Ductal adenocarcinoMa
NCT07252076 ·Status: RECRUITING
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
NCT00904410 ·Status: COMPLETED ·Phase: PHASE4
-
Magnetic Resonance Imaging (MRI) in Motion
NCT02019199 ·Status: COMPLETED
-
Dose Efficiency of Modern CT Scanners in Oncologic Scans
NCT04989192 ·Status: UNKNOWN ·Phase: NA